Volkert M, Lundstedt C
J Exp Med. 1968 Feb 1;127(2):327-39. doi: 10.1084/jem.127.2.327.
The hypothesis that treatment with antilymphocytic serum (ALS) can provoke latent virus infections has been investigated. In adult mice infections with sublethal doses of LCM virus usually result in the development of immunity to the virus and at the same time to a prolonged latent infection. In the experiments described an intensive treatment with large doses of ALS was given to mice which had recovered from LCM virus infection. At the beginning of the treatment the mice had high titers of complement-fixing antibodies in their blood and no detectable virus. The data presented show that in spite of the immunity the ALS treatment provoked the occult virus and led to the development of viremia in all the treated mice. In some, very high virus titers were demonstrable. When the ALS treatment was discontinued the viremia disappeard again. In most of the mice the ALS did not suppress the complement-fixing antibody titers and in some there was even a considerable increase in titer. In such cases the increases in virus titers and in antibody titers were closely related to one another. These results demonstrate once again that the complement-fixing antibodies to the LCM virus in mice probably do not influence the virus.
抗淋巴细胞血清(ALS)治疗可引发潜伏病毒感染这一假说已得到研究。在成年小鼠中,用亚致死剂量的淋巴细胞脉络丛脑膜炎病毒(LCM病毒)进行感染,通常会导致对该病毒产生免疫力,同时引发长期的潜伏感染。在所述实验中,对已从LCM病毒感染中恢复的小鼠给予大剂量ALS进行强化治疗。治疗开始时,小鼠血液中补体结合抗体滴度很高,且未检测到病毒。所呈现的数据表明,尽管小鼠具有免疫力,但ALS治疗仍引发了隐匿病毒,并导致所有接受治疗的小鼠出现病毒血症。在一些小鼠中,可检测到非常高的病毒滴度。当停止ALS治疗后,病毒血症再次消失。在大多数小鼠中,ALS并未抑制补体结合抗体滴度,在一些小鼠中,滴度甚至有相当大的升高。在这种情况下,病毒滴度和抗体滴度的升高彼此密切相关。这些结果再次证明,小鼠中针对LCM病毒的补体结合抗体可能不会影响该病毒。